Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OUTCOMES AND CLINICAL RELEVANCE IN PATIENTS WITH DOUBLE EXPRESSOR DLBCL Sirapat Rungwittayatiwat1, Paisarn Boonsakan2, Pichika Chantrathammachart1, Teeraya Puavilai1, Sulada Pukiat1, Sithakom Phusanti1,3, Kochawan Boonyawat1, Pathawut Wacharapornin1, Pantep Angchaisuksiri1, Artit Ungkanont1,3, Suporn Chuncharunee1 Pimjai Niparuck1
1275PDF: 598HTML: 264 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2513PDF: 1026HTML: 423Supplementary table 1: 243Some of the mutation detection samples: 248 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2325HTML: 665PDF: 1399 -
LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE
1786PDF: 832HTML: 886jdoe, table 2 infections CML .doc: 220jdoe, table 1 infections CML .doc: 206 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1112PDF: 969Suppl. Files: 619HTML: 107 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1166PDF: 1280HTML: 125 -
Skin Involvement in Primary Systemic Amyloidosis
1728PDF: 933HTML: 4424Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 201Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 179Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 207 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2092PDF: 1642HTML: 806 -
GENETIC HETEROGENEITY OF BETA GLOBIN MUTATIONS AMONG ASIAN-INDIANS AND IMPORTANCE IN GENETIC COUNSELLING AND DIAGNOSIS
1943PDF: 1340HTML: 11579Figure1: 196Figure 2: 204 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1816PDF: 591HTML: 273 -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA
2459PDF: 890HTML: 2227New table Chinese children with APL: 183 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2203PDF: 1354HTML: 3515 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1862PDF: 919HTML: 1484 -
Simultaneous dual pathology in lymph node
1720PDF: 737HTML: 7848Simultaneous dual pathology in lymph node: 196Simultaneous dual pathology in lymph node: 201Simultaneous dual pathology in lymph node: 168Simultaneous dual pathology in lymph node: 213Simultaneous dual pathology in lymph node: 204 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2346PDF: 874HTML: 970Patient’s family tree: 202 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3067PDF: 905HTML: 6617Untitled: 266Untitled: 223Untitled: 239Untitled: 253 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2343PDF: 2127HTML: 225 -
THERAPEUTIC VALUE OF COMBINED THERAPY WITH DEFERASIROX AND SILYMARIN ON IRON OVERLOAD IN CHILDREN WITH BETA THALASSEMIA
2824PDF: 870HTML: 15026Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia: 342 -
PREVENTION OF ? THALASSEMIA IN NORTHERN ISRAEL - A COST-BENEFIT ANALYSIS.
3233PDF: 1342HTML: 11861 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1762PDF: 730HTML: 3830 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2304PDF: 954HTML: 1707 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1372PDF: 1127HTML: 258 -
THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS
3004PDF: 1047HTML: 115







